nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—SLC47A1—Metformin—metabolic syndrome X	0.291	0.634	CbGbCtD
Imatinib—ALB—metabolic syndrome X	0.186	1	CbGaD
Imatinib—SLC22A2—Metformin—metabolic syndrome X	0.0901	0.196	CbGbCtD
Imatinib—SLC22A1—Metformin—metabolic syndrome X	0.0782	0.17	CbGbCtD
Imatinib—Oedema aggravated—Metformin—metabolic syndrome X	0.0491	0.398	CcSEcCtD
Imatinib—CA3—pericardium—metabolic syndrome X	0.0104	0.122	CbGeAlD
Imatinib—PDGFRA—penis—metabolic syndrome X	0.00727	0.0848	CbGeAlD
Imatinib—Loose stools—Metformin—metabolic syndrome X	0.00307	0.0249	CcSEcCtD
Imatinib—Nail disorder—Metformin—metabolic syndrome X	0.00262	0.0212	CcSEcCtD
Imatinib—ABCA3—adipose tissue—metabolic syndrome X	0.00247	0.0288	CbGeAlD
Imatinib—Heartburn—Metformin—metabolic syndrome X	0.00247	0.02	CcSEcCtD
Imatinib—DDR1—adipose tissue—metabolic syndrome X	0.00228	0.0266	CbGeAlD
Imatinib—KIT—endothelium—metabolic syndrome X	0.00227	0.0265	CbGeAlD
Imatinib—Fungal infection—Metformin—metabolic syndrome X	0.0022	0.0178	CcSEcCtD
Imatinib—KIT—blood vessel—metabolic syndrome X	0.00209	0.0244	CbGeAlD
Imatinib—Rigors—Metformin—metabolic syndrome X	0.00208	0.0169	CcSEcCtD
Imatinib—PDGFRB—blood vessel—metabolic syndrome X	0.00205	0.0239	CbGeAlD
Imatinib—Contusion—Metformin—metabolic syndrome X	0.00195	0.0158	CcSEcCtD
Imatinib—CA7—kidney—metabolic syndrome X	0.00162	0.019	CbGeAlD
Imatinib—DDR1—liver—metabolic syndrome X	0.0016	0.0186	CbGeAlD
Imatinib—CA3—cardiovascular system—metabolic syndrome X	0.00152	0.0178	CbGeAlD
Imatinib—Lightheadedness—Metformin—metabolic syndrome X	0.00152	0.0123	CcSEcCtD
Imatinib—ABL2—adipose tissue—metabolic syndrome X	0.00149	0.0173	CbGeAlD
Imatinib—PIP4K2C—adipose tissue—metabolic syndrome X	0.00141	0.0164	CbGeAlD
Imatinib—CA3—adipose tissue—metabolic syndrome X	0.00134	0.0157	CbGeAlD
Imatinib—Hypoglycaemia—Metformin—metabolic syndrome X	0.00126	0.0102	CcSEcCtD
Imatinib—Lethargy—Metformin—metabolic syndrome X	0.00126	0.0102	CcSEcCtD
Imatinib—LCK—adipose tissue—metabolic syndrome X	0.00125	0.0146	CbGeAlD
Imatinib—Pain in extremity—Metformin—metabolic syndrome X	0.00123	0.00999	CcSEcCtD
Imatinib—PTGS1—artery—metabolic syndrome X	0.00123	0.0144	CbGeAlD
Imatinib—Migraine—Metformin—metabolic syndrome X	0.00121	0.00983	CcSEcCtD
Imatinib—PDGFRA—cardiovascular system—metabolic syndrome X	0.00117	0.0136	CbGeAlD
Imatinib—Dehydration—Metformin—metabolic syndrome X	0.00115	0.00929	CcSEcCtD
Imatinib—NQO2—kidney—metabolic syndrome X	0.00115	0.0134	CbGeAlD
Imatinib—Abdominal pain upper—Metformin—metabolic syndrome X	0.00113	0.00912	CcSEcCtD
Imatinib—Breast disorder—Metformin—metabolic syndrome X	0.00111	0.00903	CcSEcCtD
Imatinib—Cramp muscle—Metformin—metabolic syndrome X	0.00111	0.009	CcSEcCtD
Imatinib—Nasopharyngitis—Metformin—metabolic syndrome X	0.0011	0.00893	CcSEcCtD
Imatinib—SLC22A2—kidney—metabolic syndrome X	0.00109	0.0127	CbGeAlD
Imatinib—Abdominal distension—Metformin—metabolic syndrome X	0.00107	0.00869	CcSEcCtD
Imatinib—Influenza—Metformin—metabolic syndrome X	0.00107	0.00863	CcSEcCtD
Imatinib—CA12—kidney—metabolic syndrome X	0.00106	0.0123	CbGeAlD
Imatinib—Pancreatitis—Metformin—metabolic syndrome X	0.00105	0.00847	CcSEcCtD
Imatinib—ABL2—liver—metabolic syndrome X	0.00104	0.0122	CbGeAlD
Imatinib—PTGS1—endothelium—metabolic syndrome X	0.00104	0.0121	CbGeAlD
Imatinib—Angina pectoris—Metformin—metabolic syndrome X	0.00104	0.00841	CcSEcCtD
Imatinib—Sweating increased—Metformin—metabolic syndrome X	0.00104	0.00841	CcSEcCtD
Imatinib—NQO2—adipose tissue—metabolic syndrome X	0.00103	0.0121	CbGeAlD
Imatinib—PDGFRA—adipose tissue—metabolic syndrome X	0.00103	0.012	CbGeAlD
Imatinib—CSF1R—cardiovascular system—metabolic syndrome X	0.00103	0.012	CbGeAlD
Imatinib—Neutropenia—Metformin—metabolic syndrome X	0.000997	0.00807	CcSEcCtD
Imatinib—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000991	0.00802	CcSEcCtD
Imatinib—PIP4K2C—liver—metabolic syndrome X	0.000987	0.0115	CbGeAlD
Imatinib—PTGS1—blood vessel—metabolic syndrome X	0.000959	0.0112	CbGeAlD
Imatinib—Infestation—Metformin—metabolic syndrome X	0.00095	0.0077	CcSEcCtD
Imatinib—Infestation NOS—Metformin—metabolic syndrome X	0.00095	0.0077	CcSEcCtD
Imatinib—CA3—liver—metabolic syndrome X	0.000942	0.011	CbGeAlD
Imatinib—KIT—cardiovascular system—metabolic syndrome X	0.000934	0.0109	CbGeAlD
Imatinib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000932	0.00755	CcSEcCtD
Imatinib—SLC47A1—kidney—metabolic syndrome X	0.00092	0.0107	CbGeAlD
Imatinib—KIT—kidney—metabolic syndrome X	0.000914	0.0107	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—metabolic syndrome X	0.000913	0.0106	CbGeAlD
Imatinib—CSF1R—adipose tissue—metabolic syndrome X	0.000907	0.0106	CbGeAlD
Imatinib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000899	0.00728	CcSEcCtD
Imatinib—PDGFRB—kidney—metabolic syndrome X	0.000893	0.0104	CbGeAlD
Imatinib—LCK—liver—metabolic syndrome X	0.000876	0.0102	CbGeAlD
Imatinib—CA14—liver—metabolic syndrome X	0.000856	0.00998	CbGeAlD
Imatinib—Rhinitis—Metformin—metabolic syndrome X	0.000855	0.00693	CcSEcCtD
Imatinib—CA1—cardiovascular system—metabolic syndrome X	0.000855	0.00997	CbGeAlD
Imatinib—Hepatitis—Metformin—metabolic syndrome X	0.000853	0.00691	CcSEcCtD
Imatinib—Hypoaesthesia—Metformin—metabolic syndrome X	0.000849	0.00688	CcSEcCtD
Imatinib—Oedema peripheral—Metformin—metabolic syndrome X	0.000841	0.00681	CcSEcCtD
Imatinib—Connective tissue disorder—Metformin—metabolic syndrome X	0.000838	0.00679	CcSEcCtD
Imatinib—CYP3A7—liver—metabolic syndrome X	0.000837	0.00976	CbGeAlD
Imatinib—CA1—kidney—metabolic syndrome X	0.000836	0.00975	CbGeAlD
Imatinib—SLC47A1—adipose tissue—metabolic syndrome X	0.000829	0.00967	CbGeAlD
Imatinib—KIT—adipose tissue—metabolic syndrome X	0.000824	0.00961	CbGeAlD
Imatinib—ABL1—cardiovascular system—metabolic syndrome X	0.000813	0.00949	CbGeAlD
Imatinib—PDGFRB—adipose tissue—metabolic syndrome X	0.000805	0.00939	CbGeAlD
Imatinib—Eye disorder—Metformin—metabolic syndrome X	0.000797	0.00646	CcSEcCtD
Imatinib—ABL1—kidney—metabolic syndrome X	0.000796	0.00928	CbGeAlD
Imatinib—Cardiac disorder—Metformin—metabolic syndrome X	0.000792	0.00641	CcSEcCtD
Imatinib—Flushing—Metformin—metabolic syndrome X	0.000792	0.00641	CcSEcCtD
Imatinib—Angiopathy—Metformin—metabolic syndrome X	0.000774	0.00627	CcSEcCtD
Imatinib—Immune system disorder—Metformin—metabolic syndrome X	0.000771	0.00624	CcSEcCtD
Imatinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.000769	0.00623	CcSEcCtD
Imatinib—SLC22A1—kidney—metabolic syndrome X	0.000767	0.00895	CbGeAlD
Imatinib—Chills—Metformin—metabolic syndrome X	0.000766	0.0062	CcSEcCtD
Imatinib—CA1—adipose tissue—metabolic syndrome X	0.000754	0.00879	CbGeAlD
Imatinib—Erythema—Metformin—metabolic syndrome X	0.000743	0.00602	CcSEcCtD
Imatinib—Malnutrition—Metformin—metabolic syndrome X	0.000743	0.00602	CcSEcCtD
Imatinib—Flatulence—Metformin—metabolic syndrome X	0.000732	0.00593	CcSEcCtD
Imatinib—Dysgeusia—Metformin—metabolic syndrome X	0.000727	0.00589	CcSEcCtD
Imatinib—NQO2—liver—metabolic syndrome X	0.000725	0.00845	CbGeAlD
Imatinib—PDGFRA—liver—metabolic syndrome X	0.000723	0.00843	CbGeAlD
Imatinib—ABL1—adipose tissue—metabolic syndrome X	0.000717	0.00837	CbGeAlD
Imatinib—Muscle spasms—Metformin—metabolic syndrome X	0.000714	0.00578	CcSEcCtD
Imatinib—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.000711	0.0083	CbGeAlD
Imatinib—Vision blurred—Metformin—metabolic syndrome X	0.0007	0.00567	CcSEcCtD
Imatinib—Tremor—Metformin—metabolic syndrome X	0.000696	0.00564	CcSEcCtD
Imatinib—SLC22A1—adipose tissue—metabolic syndrome X	0.000692	0.00807	CbGeAlD
Imatinib—Ill-defined disorder—Metformin—metabolic syndrome X	0.000689	0.00558	CcSEcCtD
Imatinib—Malaise—Metformin—metabolic syndrome X	0.00067	0.00543	CcSEcCtD
Imatinib—Syncope—Metformin—metabolic syndrome X	0.000666	0.0054	CcSEcCtD
Imatinib—Palpitations—Metformin—metabolic syndrome X	0.000656	0.00532	CcSEcCtD
Imatinib—Loss of consciousness—Metformin—metabolic syndrome X	0.000653	0.00529	CcSEcCtD
Imatinib—Hypertension—Metformin—metabolic syndrome X	0.000641	0.00519	CcSEcCtD
Imatinib—CSF1R—liver—metabolic syndrome X	0.000636	0.00742	CbGeAlD
Imatinib—Chest pain—Metformin—metabolic syndrome X	0.000632	0.00512	CcSEcCtD
Imatinib—Myalgia—Metformin—metabolic syndrome X	0.000632	0.00512	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000628	0.00509	CcSEcCtD
Imatinib—Discomfort—Metformin—metabolic syndrome X	0.000625	0.00506	CcSEcCtD
Imatinib—Oedema—Metformin—metabolic syndrome X	0.000606	0.00491	CcSEcCtD
Imatinib—Infection—Metformin—metabolic syndrome X	0.000602	0.00488	CcSEcCtD
Imatinib—Shock—Metformin—metabolic syndrome X	0.000596	0.00483	CcSEcCtD
Imatinib—Nervous system disorder—Metformin—metabolic syndrome X	0.000594	0.00482	CcSEcCtD
Imatinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.000594	0.00481	CcSEcCtD
Imatinib—Skin disorder—Metformin—metabolic syndrome X	0.000589	0.00477	CcSEcCtD
Imatinib—Hyperhidrosis—Metformin—metabolic syndrome X	0.000586	0.00475	CcSEcCtD
Imatinib—SLC47A1—liver—metabolic syndrome X	0.000581	0.00678	CbGeAlD
Imatinib—KIT—liver—metabolic syndrome X	0.000578	0.00674	CbGeAlD
Imatinib—Anorexia—Metformin—metabolic syndrome X	0.000578	0.00468	CcSEcCtD
Imatinib—ABCB1—blood vessel—metabolic syndrome X	0.000567	0.00661	CbGeAlD
Imatinib—Hypotension—Metformin—metabolic syndrome X	0.000566	0.00459	CcSEcCtD
Imatinib—PDGFRB—liver—metabolic syndrome X	0.000564	0.00658	CbGeAlD
Imatinib—CA2—cardiovascular system—metabolic syndrome X	0.000554	0.00646	CbGeAlD
Imatinib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000552	0.00447	CcSEcCtD
Imatinib—Paraesthesia—Metformin—metabolic syndrome X	0.000544	0.00441	CcSEcCtD
Imatinib—CA2—kidney—metabolic syndrome X	0.000542	0.00632	CbGeAlD
Imatinib—Dyspnoea—Metformin—metabolic syndrome X	0.00054	0.00438	CcSEcCtD
Imatinib—Somnolence—Metformin—metabolic syndrome X	0.000539	0.00437	CcSEcCtD
Imatinib—Dyspepsia—Metformin—metabolic syndrome X	0.000534	0.00432	CcSEcCtD
Imatinib—ORM1—liver—metabolic syndrome X	0.000529	0.00618	CbGeAlD
Imatinib—CA1—liver—metabolic syndrome X	0.000529	0.00616	CbGeAlD
Imatinib—Decreased appetite—Metformin—metabolic syndrome X	0.000527	0.00427	CcSEcCtD
Imatinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000523	0.00424	CcSEcCtD
Imatinib—Fatigue—Metformin—metabolic syndrome X	0.000523	0.00423	CcSEcCtD
Imatinib—Constipation—Metformin—metabolic syndrome X	0.000518	0.0042	CcSEcCtD
Imatinib—ABL1—liver—metabolic syndrome X	0.000503	0.00587	CbGeAlD
Imatinib—Feeling abnormal—Metformin—metabolic syndrome X	0.0005	0.00405	CcSEcCtD
Imatinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000496	0.00402	CcSEcCtD
Imatinib—CA2—adipose tissue—metabolic syndrome X	0.000488	0.0057	CbGeAlD
Imatinib—SLC22A1—liver—metabolic syndrome X	0.000485	0.00566	CbGeAlD
Imatinib—Urticaria—Metformin—metabolic syndrome X	0.000482	0.0039	CcSEcCtD
Imatinib—Abdominal pain—Metformin—metabolic syndrome X	0.000479	0.00388	CcSEcCtD
Imatinib—CYP2C9—cardiovascular system—metabolic syndrome X	0.000469	0.00547	CbGeAlD
Imatinib—CYP3A5—kidney—metabolic syndrome X	0.000466	0.00543	CbGeAlD
Imatinib—ALB—liver—metabolic syndrome X	0.000464	0.00542	CbGeAlD
Imatinib—ABCG2—adipose tissue—metabolic syndrome X	0.000452	0.00528	CbGeAlD
Imatinib—Asthenia—Metformin—metabolic syndrome X	0.000435	0.00352	CcSEcCtD
Imatinib—Pruritus—Metformin—metabolic syndrome X	0.000429	0.00347	CcSEcCtD
Imatinib—PTGS1—cardiovascular system—metabolic syndrome X	0.000428	0.00499	CbGeAlD
Imatinib—CYP3A5—adipose tissue—metabolic syndrome X	0.00042	0.0049	CbGeAlD
Imatinib—PTGS1—kidney—metabolic syndrome X	0.000419	0.00488	CbGeAlD
Imatinib—Diarrhoea—Metformin—metabolic syndrome X	0.000415	0.00336	CcSEcCtD
Imatinib—Dizziness—Metformin—metabolic syndrome X	0.000401	0.00325	CcSEcCtD
Imatinib—Vomiting—Metformin—metabolic syndrome X	0.000385	0.00312	CcSEcCtD
Imatinib—Rash—Metformin—metabolic syndrome X	0.000382	0.0031	CcSEcCtD
Imatinib—Dermatitis—Metformin—metabolic syndrome X	0.000382	0.00309	CcSEcCtD
Imatinib—Headache—Metformin—metabolic syndrome X	0.00038	0.00308	CcSEcCtD
Imatinib—PTGS1—adipose tissue—metabolic syndrome X	0.000377	0.0044	CbGeAlD
Imatinib—CYP2C19—liver—metabolic syndrome X	0.000374	0.00436	CbGeAlD
Imatinib—Nausea—Metformin—metabolic syndrome X	0.00036	0.00292	CcSEcCtD
Imatinib—CYP3A4—kidney—metabolic syndrome X	0.00035	0.00408	CbGeAlD
Imatinib—CYP2D6—kidney—metabolic syndrome X	0.000344	0.00401	CbGeAlD
Imatinib—CA2—liver—metabolic syndrome X	0.000343	0.004	CbGeAlD
Imatinib—ABCG2—liver—metabolic syndrome X	0.000317	0.0037	CbGeAlD
Imatinib—CYP1A2—liver—metabolic syndrome X	0.000305	0.00356	CbGeAlD
Imatinib—CYP3A5—liver—metabolic syndrome X	0.000294	0.00343	CbGeAlD
Imatinib—CYP2C9—liver—metabolic syndrome X	0.00029	0.00338	CbGeAlD
Imatinib—ABCB1—cardiovascular system—metabolic syndrome X	0.000253	0.00295	CbGeAlD
Imatinib—ABCB1—kidney—metabolic syndrome X	0.000248	0.00289	CbGeAlD
Imatinib—ABCB1—adipose tissue—metabolic syndrome X	0.000223	0.0026	CbGeAlD
Imatinib—CYP3A4—liver—metabolic syndrome X	0.000221	0.00258	CbGeAlD
Imatinib—CYP2D6—liver—metabolic syndrome X	0.000217	0.00254	CbGeAlD
Imatinib—ABCB1—liver—metabolic syndrome X	0.000156	0.00182	CbGeAlD
Imatinib—CYP3A7—Metabolism—PPARG—metabolic syndrome X	7.38e-06	5.07e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LEP—metabolic syndrome X	7.38e-06	5.07e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOE—metabolic syndrome X	7.38e-06	5.07e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARG—metabolic syndrome X	7.37e-06	5.06e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	7.37e-06	5.06e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT2—metabolic syndrome X	7.37e-06	5.06e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	7.35e-06	5.05e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—metabolic syndrome X	7.32e-06	5.03e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—LPL—metabolic syndrome X	7.31e-06	5.02e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—INS—metabolic syndrome X	7.31e-06	5.02e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOA1—metabolic syndrome X	7.3e-06	5.01e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—metabolic syndrome X	7.29e-06	5.01e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	7.29e-06	5.01e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	7.26e-06	4.99e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—INS—metabolic syndrome X	7.24e-06	4.97e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—INS—metabolic syndrome X	7.23e-06	4.97e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SERPINE1—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LIPC—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GCK—metabolic syndrome X	7.22e-06	4.96e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	7.2e-06	4.95e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	7.2e-06	4.95e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.17e-06	4.93e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOC3—metabolic syndrome X	7.17e-06	4.93e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARG—metabolic syndrome X	7.16e-06	4.92e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	7.03e-06	4.83e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	7.03e-06	4.83e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—INS—metabolic syndrome X	7.02e-06	4.82e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	7.01e-06	4.82e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	7.01e-06	4.82e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT1—metabolic syndrome X	6.98e-06	4.79e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT1—metabolic syndrome X	6.98e-06	4.79e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CETP—metabolic syndrome X	6.96e-06	4.78e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CD36—metabolic syndrome X	6.95e-06	4.77e-05	CbGpPWpGaD
Imatinib—CA2—Metabolism—AKT1—metabolic syndrome X	6.91e-06	4.75e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOS3—metabolic syndrome X	6.89e-06	4.73e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARG—metabolic syndrome X	6.87e-06	4.72e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.81e-06	4.68e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.81e-06	4.68e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	6.79e-06	4.66e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—AKT1—metabolic syndrome X	6.75e-06	4.64e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—INS—metabolic syndrome X	6.74e-06	4.63e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	6.72e-06	4.62e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—metabolic syndrome X	6.7e-06	4.6e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	6.67e-06	4.58e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.65e-06	4.57e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—metabolic syndrome X	6.64e-06	4.56e-05	CbGpPWpGaD
Imatinib—CA1—Metabolism—AKT1—metabolic syndrome X	6.63e-06	4.55e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—metabolic syndrome X	6.63e-06	4.55e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	6.62e-06	4.55e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	6.62e-06	4.55e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOB—metabolic syndrome X	6.59e-06	4.53e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IRS1—metabolic syndrome X	6.59e-06	4.52e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	6.57e-06	4.51e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	6.57e-06	4.51e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—metabolic syndrome X	6.51e-06	4.47e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.49e-06	4.46e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—AKT1—metabolic syndrome X	6.48e-06	4.45e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	6.47e-06	4.45e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARA—metabolic syndrome X	6.46e-06	4.44e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—metabolic syndrome X	6.45e-06	4.43e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—metabolic syndrome X	6.44e-06	4.42e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT1—metabolic syndrome X	6.42e-06	4.41e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT1—metabolic syndrome X	6.42e-06	4.41e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PLA2G4A—metabolic syndrome X	6.41e-06	4.41e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NOS3—metabolic syndrome X	6.41e-06	4.4e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT1—metabolic syndrome X	6.36e-06	4.37e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT1—metabolic syndrome X	6.36e-06	4.37e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NOS3—metabolic syndrome X	6.35e-06	4.36e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NOS3—metabolic syndrome X	6.34e-06	4.36e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—INS—metabolic syndrome X	6.31e-06	4.33e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	6.3e-06	4.32e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT2—metabolic syndrome X	6.3e-06	4.32e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—LPL—metabolic syndrome X	6.3e-06	4.32e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AGT—metabolic syndrome X	6.25e-06	4.3e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.25e-06	4.29e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—metabolic syndrome X	6.23e-06	4.28e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL2—metabolic syndrome X	6.2e-06	4.26e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—metabolic syndrome X	6.18e-06	4.24e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NOS3—metabolic syndrome X	6.16e-06	4.23e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOE—metabolic syndrome X	6.13e-06	4.21e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF1—metabolic syndrome X	6.1e-06	4.19e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOA1—metabolic syndrome X	6.06e-06	4.16e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CD36—metabolic syndrome X	5.98e-06	4.11e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOB—metabolic syndrome X	5.92e-06	4.07e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—metabolic syndrome X	5.91e-06	4.06e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—metabolic syndrome X	5.9e-06	4.05e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	5.86e-06	4.03e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—AKT1—metabolic syndrome X	5.83e-06	4e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	5.81e-06	3.99e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	5.8e-06	3.98e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SERPINE1—metabolic syndrome X	5.79e-06	3.98e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOB—metabolic syndrome X	5.78e-06	3.97e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	5.76e-06	3.96e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—metabolic syndrome X	5.75e-06	3.95e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—AKT1—metabolic syndrome X	5.75e-06	3.95e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.68e-06	3.9e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—LPL—metabolic syndrome X	5.65e-06	3.88e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—metabolic syndrome X	5.63e-06	3.87e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.62e-06	3.86e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	5.61e-06	3.85e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	5.61e-06	3.85e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	5.6e-06	3.85e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	5.57e-06	3.83e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	5.57e-06	3.83e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARA—metabolic syndrome X	5.56e-06	3.82e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	5.53e-06	3.8e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—metabolic syndrome X	5.53e-06	3.8e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—LPL—metabolic syndrome X	5.52e-06	3.79e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—metabolic syndrome X	5.5e-06	3.77e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOB—metabolic syndrome X	5.44e-06	3.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—metabolic syndrome X	5.44e-06	3.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—AKT1—metabolic syndrome X	5.44e-06	3.74e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—metabolic syndrome X	5.44e-06	3.73e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—metabolic syndrome X	5.44e-06	3.73e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	5.41e-06	3.71e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOB—metabolic syndrome X	5.4e-06	3.71e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—AGT—metabolic syndrome X	5.39e-06	3.7e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.37e-06	3.69e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CD36—metabolic syndrome X	5.37e-06	3.69e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—metabolic syndrome X	5.34e-06	3.67e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—metabolic syndrome X	5.34e-06	3.67e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—metabolic syndrome X	5.31e-06	3.65e-05	CbGpPWpGaD
Imatinib—KIT—Disease—AKT1—metabolic syndrome X	5.3e-06	3.64e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	5.3e-06	3.64e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—metabolic syndrome X	5.28e-06	3.62e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	5.25e-06	3.61e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CD36—metabolic syndrome X	5.24e-06	3.6e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—INS—metabolic syndrome X	5.23e-06	3.6e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—metabolic syndrome X	5.22e-06	3.59e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOA1—metabolic syndrome X	5.22e-06	3.58e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.2e-06	3.57e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—metabolic syndrome X	5.18e-06	3.56e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—LPL—metabolic syndrome X	5.15e-06	3.54e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.15e-06	3.53e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AKT1—metabolic syndrome X	5.07e-06	3.48e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—metabolic syndrome X	5.06e-06	3.47e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—AKT1—metabolic syndrome X	5.02e-06	3.45e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5e-06	3.43e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARA—metabolic syndrome X	4.99e-06	3.43e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CD36—metabolic syndrome X	4.94e-06	3.39e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—metabolic syndrome X	4.9e-06	3.37e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—AKT1—metabolic syndrome X	4.9e-06	3.37e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CD36—metabolic syndrome X	4.9e-06	3.36e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.87e-06	3.35e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	4.86e-06	3.34e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	4.86e-06	3.34e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AGT—metabolic syndrome X	4.84e-06	3.32e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—metabolic syndrome X	4.8e-06	3.3e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—AKT1—metabolic syndrome X	4.77e-06	3.28e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—metabolic syndrome X	4.74e-06	3.25e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AGT—metabolic syndrome X	4.72e-06	3.24e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOA1—metabolic syndrome X	4.68e-06	3.22e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—metabolic syndrome X	4.62e-06	3.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOB—metabolic syndrome X	4.61e-06	3.17e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—metabolic syndrome X	4.6e-06	3.16e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARA—metabolic syndrome X	4.59e-06	3.15e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—metabolic syndrome X	4.59e-06	3.15e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.57e-06	3.14e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—metabolic syndrome X	4.56e-06	3.13e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARA—metabolic syndrome X	4.55e-06	3.13e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—AKT1—metabolic syndrome X	4.52e-06	3.11e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—INS—metabolic syndrome X	4.51e-06	3.1e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	4.49e-06	3.08e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—AKT1—metabolic syndrome X	4.48e-06	3.08e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AGT—metabolic syndrome X	4.45e-06	3.05e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AGT—metabolic syndrome X	4.41e-06	3.03e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LPL—metabolic syndrome X	4.4e-06	3.02e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—metabolic syndrome X	4.36e-06	2.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.33e-06	2.98e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.33e-06	2.98e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—metabolic syndrome X	4.32e-06	2.97e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.31e-06	2.96e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOA1—metabolic syndrome X	4.27e-06	2.93e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—metabolic syndrome X	4.26e-06	2.93e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	4.2e-06	2.88e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.19e-06	2.88e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.19e-06	2.88e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CD36—metabolic syndrome X	4.18e-06	2.87e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—metabolic syndrome X	4.13e-06	2.83e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—INS—metabolic syndrome X	4.05e-06	2.78e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.03e-06	2.77e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—metabolic syndrome X	4.03e-06	2.77e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—metabolic syndrome X	3.95e-06	2.72e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—INS—metabolic syndrome X	3.95e-06	2.71e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—metabolic syndrome X	3.94e-06	2.7e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—AKT1—metabolic syndrome X	3.93e-06	2.7e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARA—metabolic syndrome X	3.89e-06	2.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—metabolic syndrome X	3.81e-06	2.62e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—metabolic syndrome X	3.8e-06	2.61e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AGT—metabolic syndrome X	3.77e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—metabolic syndrome X	3.76e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—INS—metabolic syndrome X	3.72e-06	2.56e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AKT1—metabolic syndrome X	3.71e-06	2.55e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—metabolic syndrome X	3.71e-06	2.55e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—metabolic syndrome X	3.69e-06	2.54e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—INS—metabolic syndrome X	3.69e-06	2.53e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—metabolic syndrome X	3.66e-06	2.51e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOA1—metabolic syndrome X	3.65e-06	2.51e-05	CbGpPWpGaD
Imatinib—LCK—Disease—AKT1—metabolic syndrome X	3.63e-06	2.49e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—metabolic syndrome X	3.62e-06	2.49e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—metabolic syndrome X	3.62e-06	2.48e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.56e-06	2.44e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—metabolic syndrome X	3.55e-06	2.44e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AKT1—metabolic syndrome X	3.52e-06	2.42e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.46e-06	2.38e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.46e-06	2.38e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—metabolic syndrome X	3.43e-06	2.36e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.41e-06	2.34e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.4e-06	2.33e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—metabolic syndrome X	3.38e-06	2.32e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.26e-06	2.24e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	3.25e-06	2.23e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—metabolic syndrome X	3.24e-06	2.22e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.23e-06	2.22e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—metabolic syndrome X	3.22e-06	2.21e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.17e-06	2.18e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AKT1—metabolic syndrome X	3.17e-06	2.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—INS—metabolic syndrome X	3.15e-06	2.17e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3e-06	2.06e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.99e-06	2.05e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	2.96e-06	2.03e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AKT1—metabolic syndrome X	2.95e-06	2.02e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AKT1—metabolic syndrome X	2.92e-06	2.01e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AKT1—metabolic syndrome X	2.91e-06	2e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.91e-06	2e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.89e-06	1.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.85e-06	1.96e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AKT1—metabolic syndrome X	2.83e-06	1.94e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.82e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—metabolic syndrome X	2.77e-06	1.9e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—metabolic syndrome X	2.76e-06	1.89e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AKT1—metabolic syndrome X	2.72e-06	1.87e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AKT1—metabolic syndrome X	2.54e-06	1.75e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.53e-06	1.74e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.48e-06	1.7e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—INS—metabolic syndrome X	2.43e-06	1.67e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.23e-06	1.53e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.13e-06	1.47e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AKT1—metabolic syndrome X	2.11e-06	1.45e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.95e-06	1.34e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—AKT1—metabolic syndrome X	1.82e-06	1.25e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.63e-06	1.12e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.59e-06	1.09e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.5e-06	1.03e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.49e-06	1.02e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.27e-06	8.73e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	9.81e-07	6.74e-06	CbGpPWpGaD
